An 84-year-old woman with diabetes mellitus, frailty (5/6), preserved LV function, and aortic stenosis previously treated with CoreValve 26 mm in 2016, presented with symptomatic degenerative stenosis of the valve.
A Sapien 3 (23 mm) was implanted without predilatation but with post-dilatation under general anaesthesia, using cerebral...

A 77-year-old male with a history of SAVR in 2011 (Magna Ease 23) and moderate chronic kidney disease, with preservedLV function, presented with symptomatic severe aortic regurgitation and stenosis, associated with severe MR.

A Sapien 3 Ultra Resilia 23 valve was implanted under local anesthesia, with hemodynamic...

An 82-year-old male with a history of STEMI in 2013, stroke in 2018, cancer, and permanent AF, presented with acute heart failure with predominant right-side failure. Severe tricuspid regurgitation was identified.
The operators implanted an Evoque valve percutaneously under TEE guidance and general anaesthesia via the venous...

Join us for a LIVE case followed by a recorded case highlighting advanced treatments for severe secondary mitral regurgitation:

• A 75-year-old man with permanent AF, a history of CABG, and symptomatic severe secondary MR (atrial and ischemic causes) with low LV function (45%) underwent mitral repair with...

A 53-year-old male with a history of advanced malignancy (lung adenoma) and mid LAD PCI last year, along with multiple risk factors (hypertension, dyslipidemia, diabetes, and smoking), presented with angina and a positive stress test and CT. The angiography and CT showed significant left main stenosis...

Kenny Kent was very influential in setting up the new specialty of Interventional Cardiology based on well collected and adjudicated data, which paved the path for the subsequent randomized clinical trials. Without his contributions, our specialty may have been like many others in Medicine, just an...

The COVID-19 crisis heralds a new set of rules; perhaps for the first time, we anticipate that the near future will be different than we can imagine. Like so many times in the past, healthcare professionals and scientists will continue being in the eye of the...

Andreas Grüntzig’s vision and perspicacity drove an entire new field of cardiology. This page is dedicated to his personal life and accomplishments with a dedicated tribute from Spencer B. King III

Philippe Gaspard, an interventional cardiologist with over 35 years’ experience, was a firsthand witness of angioplasty’s early years. In his book “The History of Coronary Angioplasty” the author guides us through the field’s evolution while offering personal insights into the “paradigm shift” that followed the work...

REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta-blocker treatment in patients with acute MI and an ejection fraction >50% treated with a contemporary reperfusion strategy.

Nicola Ryan and Ali Nazmi Calik provide their take on the results which were presented...